Curium US PET LLC – FDA 483, Apr 18, 2025
Curium US LLC in Noblesville, Indiana, a drug substance and drug product manufacturer, was cited for significant deficiencies during an FDA inspection. Observations included inadequate controls over computer systems and electronic data, insufficient investigations into out-of-specification laboratory results, and failures in aseptic processing procedures to prevent microbiological contamination of sterile drug products. These issues indicate a lack of robust quality control and data integrity practices.
ID · cf532db8-b7a4-4eac-b7a1-ecf3881080d1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.